Optum Ventures

Optum Ventures provides capital and strategic guidance to startup companies solving health care's pressing challenges. It is the venture capital investment arm of Optum that invests in digital health companies that use data and insights to help improve consumers' access to health care services and how care is delivered and paid for, and that makes the health care system more reliable and easier to navigate.

Eliza Loring McGinn

Vice President

Heather Roxborough

Partner

89 past transactions

Caresyntax

Series C in 2024
Caresyntax Inc. is a Boston-based company that provides a digital surgery platform designed to enhance surgical performance and improve patient outcomes. The platform integrates various data sources, including video, audio, and clinical information, to deliver actionable insights for operating room (OR) teams. By leveraging advanced analytics and IoT technology, Caresyntax enables healthcare organizations to benchmark surgical outcomes, optimize resource utilization, and reduce variability in clinical performance. The software is utilized in over 4,000 operating rooms globally, supporting more than 30,000 surgeons and impacting the care of over 2 million patients each year. The company offers solutions that facilitate real-time reporting and workflow automation, allowing hospitals to mitigate risks and improve surgical training without the extensive investment typical of traditional big data analytics. Founded in 1991, Caresyntax continues to advance the use of technology in healthcare to drive better surgical practices and outcomes.

Heartbeat Health

Series C in 2024
Heartbeat Health, Inc. is a healthcare technology company based in New York that specializes in providing virtual cardiovascular disease prevention and management services. Founded in 2017, it offers a data-driven platform that enables real-time consultations between patients and cardiologists. Through its web-based services, Heartbeat Health facilitates secure communication, allowing patients to receive medical advice, treatment, and dietary consultations from healthcare professionals. The company's focus is on reducing cardiovascular risk and improving patient outcomes by promoting continuous engagement and monitoring of heart health. By leveraging technology, Heartbeat Health aims to enhance the quality of care for patients and support at-risk organizations in managing cardiovascular conditions more effectively.

Nema Health

Seed Round in 2023
Nema Health is focused on delivering comprehensive trauma care through an online platform, specifically designed for individuals affected by post-traumatic stress disorder (PTSD). The company provides a virtual care center that enables trauma survivors to receive cognitive processing therapy from PTSD-trained therapists in the comfort and privacy of their homes. Nema Health's approach aims to offer effective and lasting relief for those dealing with the impacts of trauma.

Greater Good Health

Series A in 2023
Greater Good Health is a healthcare organization focused on increasing access to value-based, holistic primary care, particularly in underserved and rural communities. Utilizing a Nurse Practitioner-led model, the organization collaborates with health plans to establish primary care practices and partners with risk-bearing organizations to implement private-labeled clinical programs. These initiatives aim to facilitate a transition to outcomes-focused care while enhancing patient experience. Greater Good Health's platform provides nurse practitioners with essential resources and tools to deliver quality, whole-person care, ultimately benefiting patients, providers, and payers alike by improving health outcomes and reducing overall costs.

Cortica

Series D in 2023
Cortica Inc. is a healthcare company that specializes in providing neurological therapies for children with autism and other neurodevelopmental challenges. Founded in 2014 and based in San Diego, California, Cortica offers a range of services including diagnoses for autism, ADHD, developmental delays, and other developmental differences. The company's treatment approach is tailored to each child, based on a comprehensive understanding of their neurobiology and developmental profile. Cortica provides customized treatment programs through in-home, in-clinic, and telehealth services. Its offerings encompass various interventions such as gene sequencing, metabolic testing, electroencephalography, nutrition evaluation, medication management, and multiple therapeutic modalities including ABA therapy, speech-language therapy, occupational therapy, physical therapy, and music therapy. The company operates centers in several locations across California, including Carlsbad, Irvine, San Rafael, Torrance, and Westlake Village.

BehaVR

Series B in 2022
BehaVR, LLC, established in 2016 and headquartered in Elizabethtown, Kentucky, operates a virtual reality platform designed to enhance practices and treatments within the healthcare sector. The company specializes in developing digital therapeutics for behavioral health, particularly at the intersection of behavioral health and chronic disease management. BehaVR's focus is on fostering skills such as stress resilience, emotional regulation, and self-efficacy, which aid individuals in coping with their conditions, adhering to care plans, and ultimately improving their overall health outcomes.

DispatchHealth

Venture Round in 2022
DispatchHealth Management, LLC specializes in on-demand mobile and virtual healthcare services, aimed at delivering quality care directly to patients in their homes. Founded in 2013 and based in Denver, Colorado, the company provides a wide range of medical services, including evaluations for acute injuries and illnesses, laceration repairs, splinting, and treatment for conditions such as nosebleeds. Additionally, DispatchHealth offers vital medical procedures like Foley catheter and G-tube placements, medication administration, laboratory testing, and outpatient imaging arrangements. With a focus on convenience and integration, the company enhances the capabilities of patients' care teams while striving to reduce healthcare costs.

Digital Diagnostics

Series B in 2022
Digital Diagnostics Inc. is an artificial intelligence diagnostics company focused on enhancing the quality, accessibility, and affordability of healthcare through advanced technology. Founded in 2010 in Coralville, Iowa, by Michael Abramoff, the company has developed a range of autonomous algorithms that analyze medical images to detect various diseases. Its flagship products include IDx-DR for diabetic retinopathy, IDx-G for glaucoma indicators, and IDx-AMD for age-related macular degeneration. Additionally, Digital Diagnostics provides algorithms for detecting other conditions such as Alzheimer's disease and cardiovascular risks. By eliminating the diagnostic burden from specialists, the company's AI platform aims to establish a new standard of care, democratizing healthcare and improving patient outcomes. The company collaborates with patient advocacy groups and regulatory bodies to facilitate the adoption of its innovative solutions both in the United States and internationally.

Alma

Series D in 2022
Alma is a membership-based network for mental health care providers that aims to improve access to high-quality, affordable mental health care. Its platform enables providers to accept insurance and also provides a member directory, client-matching service, scheduling, and billing functions, as well as education, training, and a community for support.

Medallion

Series C in 2022
Medallion is a company that offers a network management platform tailored for the healthcare industry, focusing on simplifying the complex processes of licensing, credentialing, and payer enrollment. Founded in 2020 by Derek Lo and based in San Francisco, California, Medallion's all-in-one platform addresses the logistical challenges that healthcare providers and telemedicine companies face, enabling them to minimize time spent on administrative tasks. Key features of the platform include facilities for new licensing and renewals, primary source verification, continuing medical education tracking, and document management. By streamlining these processes, Medallion allows healthcare professionals to concentrate more on patient care rather than paperwork.

CareBridge Health

Series C in 2022
CareBridge is a technology and services provider based in Nashville, Tennessee, dedicated to improving the lives of individuals with physical, intellectual, or developmental disabilities who receive home and community-based services. Founded in 2009, the company specializes in assisting health plans and states by offering comprehensive solutions such as electronic visit verification, data aggregation, and 24/7 clinical support. CareBridge focuses on ensuring that Medicaid recipients, as well as those dually eligible for Medicare and Medicaid, receive the necessary services, equipment, and support to maintain their independence at home. By facilitating continuous communication between patients, their families, and caregivers, CareBridge enhances the quality of care and promotes a supportive environment for those they serve.

Loop

Series B in 2022
By using data, technology, and high quality medical expertise, we aim to deliver an empathetic people-centric healthcare experience that helps people live longer.

DUOS

Series A in 2022
DUOS is a technology-enabled service provider connecting Medicare beneficiaries to the resources needed to attain the highest level of health. Our proactive and personalized activation platform engages your membership throughout their health journey, delivering quality health outcomes and improving member satisfaction for our valued partners. Our underlying technology aggregates historically siloed data and resources from across the ecosystem, removing barriers to health literacy and access to care, and facilitating contextual and timely connections with closed loop visibility.

Brightline

Series C in 2022
Brightline, Inc. is a provider of pediatric behavioral health care services, established in 2019 and headquartered in Palo Alto, California. The company offers a range of services including behavior therapy, psychiatry and medication support, speech-language therapy, and occupational therapy. Brightline operates as a technology-enabled behavioral health home, utilizing innovative technology and virtual services to deliver integrated care. Its collaborative care team focuses on supporting children throughout their developmental stages and addressing the needs of their families. Brightline was previously known as Emilio Health, Inc. and rebranded in May 2020.

Vira Health

Series A in 2022
Vira Health is a digital health company dedicated to enhancing long-term health outcomes for women by focusing on female-specific conditions. The company develops digital therapeutics that provide evidence-based interventions for managing menopause symptoms, including insomnia, anxiety, depression, hot flushes, weight gain, and incontinence. Vira's approach also aims to delay the onset of chronic health issues such as osteoporosis, cardiovascular disease, and dementia through personalized care and tailored treatment plans. By improving the collection and use of female health data, Vira Health seeks to address the unique challenges women face throughout their lives, particularly during menopause.

Flume Health

Series A in 2022
Flume Health Inc. is a third-party administrator of health plans, established in 2018 and based in New York. The company focuses on making self-insured health plans more affordable and user-friendly. By leveraging advanced payment technology and exceptional customer support, Flume Health enables its members to access healthcare providers at costs 20-40% lower than traditional network rates. Their health plan administration platform features a virtual assistant that addresses healthcare-related inquiries, facilitates private communication with trained care guides, and provides data to identify quality medical care at competitive prices. Additionally, the platform assists users in booking appointments and setting reminders, ensuring that clients can find affordable medical providers tailored to their needs.

Scipher Medicine

Series D in 2022
Scipher Medicine is a biotechnology company that has developed a precision medicine platform aimed at improving drug therapy outcomes for patients with cardiovascular and autoimmune diseases. The company's flagship products, including PrismDx, PrismRA, and PrismUC, utilize molecular testing to predict patient responses to specific drug therapies, enabling healthcare providers to prescribe more effective treatments tailored to individual patient needs. For example, PrismRA identifies rheumatoid arthritis patients who are unlikely to respond to certain anti-TNF therapies, allowing for timely alternative treatments. By leveraging a simple blood sample to analyze RNA and generate genomic signatures, Scipher Medicine helps healthcare professionals select the most suitable therapies based on the underlying biology of diseases rather than relying on traditional classifications or symptomatic assessments. This innovative approach not only enhances patient care but also addresses significant inefficiencies in the healthcare system, reducing costs associated with ineffective treatments. Scipher Medicine, incorporated in 2013 and based in Waltham, Massachusetts, aims to transform drug prescribing and development through its advanced molecular technology.

Secureframe

Series B in 2022
Secureframe, Inc., established in 2020 and headquartered in San Francisco, California, offers a compliance automation platform designed to assist organizations in achieving and maintaining compliance with various security and privacy standards. The platform automates compliance audits and facilitates ongoing monitoring, helping businesses manage their data securely and protect client privacy. Secureframe serves a diverse clientele, including fast-growing companies such as AngelList, Ramp, Remote, and Coda, by simplifying their compliance processes with global standards like SOC 2, ISO 27001, PCI DSS, HIPAA, and GDPR. This empowers businesses to build trust with customers through efficient and effective compliance management.

Somatus

Series E in 2022
Somatus, Inc. is a healthcare company based in McLean, Virginia, specializing in kidney care services. Founded in 2016, it partners with health plans, health systems, nephrology, and primary care groups to offer integrated care for patients with or at risk of developing kidney disease. The company provides a range of services, including home hemodialysis, peritoneal dialysis, in-center hemodialysis, kidney transplantation, and conservative care. Somatus focuses on delaying or preventing the progression of chronic kidney disease and aims to enhance the quality of care through improved coordination and increased utilization of home dialysis and transplantation options. Its approach combines vertically integrated clinical services and technology to optimize patient outcomes.

Equip Health

Series B in 2022
Equip is a virtual program helping families recover from eating disorders at home with comprehensive, gold-standard care created by experts in the field and people in recovery. Equip’s five-person care teams include dieticians, physicians, therapists, and mentors who deliver wrap-around support to provide families progress and lasting recovery. Kristina Saffran and Erin Parks co-founded the company in San Diego, California in 2019.

Future

Series C in 2022
Future offers one-on-one digital training with fitness coaches, at home, at the gym, or on-the-go. Future pairs its clients with coaches who have trained pro athletes, Hollywood celebrities, and working professionals.

mPulse Mobile

Venture Round in 2022
mPulse Mobile, Inc. develops healthcare communication technology solutions focused on consumer health and wellness. The company offers a cloud-based intelligent mobile messaging platform designed to address various challenges in healthcare, including missed appointments, medication adherence, and disease management. Its solutions encompass medication adherence, preventive care, chronic condition management, and optimizing call center operations, serving a diverse clientele that includes Medicare, Medicaid, commercial plans, health systems, and pharmacies. By integrating conversational AI and digital engagement strategies, mPulse Mobile helps healthcare organizations encourage customers to adopt healthier behaviors. Founded in 2014, the company is headquartered in Encino, California.

Garner Health

Series B in 2021
Garner Health is a provider of healthcare services used to help employers give their employees a better healthcare experience. The company offers its solution through employers who want to give their employees a better quality healthcare experience and in-turn save on the cost of healthcare because the best doctors end up costing the least money. Garner Health was founded in 2019 and is headquartered in New York.

Holmusk

Venture Round in 2021
Holmusk is a health data analytics company focused on enhancing treatment for mental health and chronic diseases. It develops a real-world evidence platform that integrates specialty behavioral health data with advanced analytics to provide evidence-based insights for treatment decisions. By leveraging artificial intelligence and data science, Holmusk accelerates research and improves patient outcomes through predictive algorithms. Its proprietary modeling platform enables clients to analyze real-world data, facilitating personalized medicine and driving data-driven approaches in healthcare. The company's mission is to expand evidence-based care for individuals managing behavioral health conditions, ultimately supporting the commercialization of new treatments.

Medallion

Series B in 2021
Medallion is a company that offers a network management platform tailored for the healthcare industry, focusing on simplifying the complex processes of licensing, credentialing, and payer enrollment. Founded in 2020 by Derek Lo and based in San Francisco, California, Medallion's all-in-one platform addresses the logistical challenges that healthcare providers and telemedicine companies face, enabling them to minimize time spent on administrative tasks. Key features of the platform include facilities for new licensing and renewals, primary source verification, continuing medical education tracking, and document management. By streamlining these processes, Medallion allows healthcare professionals to concentrate more on patient care rather than paperwork.

Caresyntax

Series C in 2021
Caresyntax Inc. is a Boston-based company that provides a digital surgery platform designed to enhance surgical performance and improve patient outcomes. The platform integrates various data sources, including video, audio, and clinical information, to deliver actionable insights for operating room (OR) teams. By leveraging advanced analytics and IoT technology, Caresyntax enables healthcare organizations to benchmark surgical outcomes, optimize resource utilization, and reduce variability in clinical performance. The software is utilized in over 4,000 operating rooms globally, supporting more than 30,000 surgeons and impacting the care of over 2 million patients each year. The company offers solutions that facilitate real-time reporting and workflow automation, allowing hospitals to mitigate risks and improve surgical training without the extensive investment typical of traditional big data analytics. Founded in 1991, Caresyntax continues to advance the use of technology in healthcare to drive better surgical practices and outcomes.

Alma

Series C in 2021
Alma is a membership-based network for mental health care providers that aims to improve access to high-quality, affordable mental health care. Its platform enables providers to accept insurance and also provides a member directory, client-matching service, scheduling, and billing functions, as well as education, training, and a community for support.

Calibrate

Series B in 2021
Calibrate is a digital health company focused on improving metabolic health to achieve sustainable weight loss. Founded in 2020 and based in New York, Calibrate offers a virtual weight management program that integrates FDA-approved metabolic medications with personalized coaching and a comprehensive curriculum designed by experts in obesity and nutrition. The platform emphasizes behavior change and provides one-on-one virtual sessions with healthcare professionals, aiming to foster lasting habits for its users. Calibrate's approach combines telemedicine with a value-based pricing model, ensuring effective obesity treatment outcomes while facilitating the necessary physiological changes for improved health.

Ultromics

Series B in 2021
They are building world-class diagnostic aids to help cardiologists — powered by artificial intelligence. To date, they have developed the world’s most accurate echocardiography software to improve the diagnosis of coronary heart disease by more than 90%.

Rey

Series A in 2021
Rey is a membership-based, on-demand mental health company on a mission to revolutionize mental health and wellness by improving access to personalized services through technology.

Brightline

Series B in 2021
Brightline, Inc. is a provider of pediatric behavioral health care services, established in 2019 and headquartered in Palo Alto, California. The company offers a range of services including behavior therapy, psychiatry and medication support, speech-language therapy, and occupational therapy. Brightline operates as a technology-enabled behavioral health home, utilizing innovative technology and virtual services to deliver integrated care. Its collaborative care team focuses on supporting children throughout their developmental stages and addressing the needs of their families. Brightline was previously known as Emilio Health, Inc. and rebranded in May 2020.

LetsGetChecked

Series D in 2021
LetsGetChecked is an at-home health testing platform that connects customers with regulated laboratory testing, enabling individuals to manage their health effectively. Based in New York, the company offers a wide range of testing kits for general wellness, sexual health, women's health, men's health, and specific illnesses, including cancer and fertility issues. Users can order testing kits online, collect samples such as blood or urine, and return them using prepaid envelopes. The analyzed results are then uploaded online, providing customers with convenient access to their health information. LetsGetChecked operates nationwide in the United States and extends its services to Canada and Europe, promoting a patient-led approach to healthcare through technology.

Medallion

Series A in 2021
Medallion is a company that offers a network management platform tailored for the healthcare industry, focusing on simplifying the complex processes of licensing, credentialing, and payer enrollment. Founded in 2020 by Derek Lo and based in San Francisco, California, Medallion's all-in-one platform addresses the logistical challenges that healthcare providers and telemedicine companies face, enabling them to minimize time spent on administrative tasks. Key features of the platform include facilities for new licensing and renewals, primary source verification, continuing medical education tracking, and document management. By streamlining these processes, Medallion allows healthcare professionals to concentrate more on patient care rather than paperwork.

Main Street Health

Series A in 2021
Main Street Health is a provider of value-based, care-focused healthcare services aimed at addressing rural wellness concerns. The company's healthcare services are data-driven, and it provides partner clinics with employees, technology, critical access hospitals, community health centers, and possibilities to flourish in the care delivery model, allowing rural residents to receive the high-quality treatment they need.

Heartbeat Health

Series B in 2021
Heartbeat Health, Inc. is a healthcare technology company based in New York that specializes in providing virtual cardiovascular disease prevention and management services. Founded in 2017, it offers a data-driven platform that enables real-time consultations between patients and cardiologists. Through its web-based services, Heartbeat Health facilitates secure communication, allowing patients to receive medical advice, treatment, and dietary consultations from healthcare professionals. The company's focus is on reducing cardiovascular risk and improving patient outcomes by promoting continuous engagement and monitoring of heart health. By leveraging technology, Heartbeat Health aims to enhance the quality of care for patients and support at-risk organizations in managing cardiovascular conditions more effectively.

Recover Together

Series C in 2021
Recover Together, Inc. operates private clinics that specialize in treating opioid addiction through a comprehensive approach that includes medication-assisted treatment and therapy. Founded in 2014 and headquartered in Manchester, New Hampshire, the company offers services across multiple states, including California, Indiana, Maine, Michigan, West Virginia, and North Carolina. Its treatment model combines the use of Suboxone (buprenorphine) with weekly group therapy sessions, allowing patients to engage in a supportive community while working toward their recovery goals. The organization is committed to making addiction treatment respectful, accessible, and affordable, empowering individuals to regain control of their lives and improve their overall quality of life.

Vim

Series B in 2021
Vim, Inc. is a healthcare technology company founded in 2015 and based in San Francisco, California. The company develops a platform that enhances the connection between patients and healthcare providers by offering online services for finding, scheduling, and receiving care. Its solutions include online booking and referral coordination, facilitating seamless communication and data sharing among health plans, patients, and a wide range of medical providers, from independent practitioners to large healthcare systems. Vim's platform integrates with electronic health records, enabling real-time access to patient data and insights at the point of care. By improving connectivity within clinical operations, Vim aims to support the delivery of affordable, high-quality healthcare.

Kaia Health

Series C in 2021
Kaia Health is a digital therapeutics company that specializes in developing evidence-based treatments for various disorders, including back pain and chronic obstructive pulmonary disease (COPD). Founded in 2016 and headquartered in Brooklyn, New York, the company utilizes machine learning to provide personalized app interventions designed to empower patients in self-managing their conditions from home using familiar devices like smartphones and tablets. Kaia Health's platform delivers tailored daily plans that incorporate exercises, relaxation techniques, and educational content, allowing users to customize their programs according to personal preferences. To date, the company has enrolled over 400,000 users in its digital therapy program.

Unite Us

Series C in 2021
Unite Us is a veteran-led technology company that specializes in creating coordinated care networks that connect health and social service providers. Founded in 2013 by veterans Dan Brillman and Taylor Justice in New York, the company focuses on integrating social determinants of health into patient care to enhance the delivery of services. Its platform enables providers to securely send and receive referrals, track each individual's health journey, and report on outcomes across various services. By fostering a centralized and collaborative ecosystem, Unite Us empowers communities to move beyond traditional resource directories, allowing them to effectively measure impact and improve health outcomes at scale.

Equip Health

Series A in 2021
Equip is a virtual program helping families recover from eating disorders at home with comprehensive, gold-standard care created by experts in the field and people in recovery. Equip’s five-person care teams include dieticians, physicians, therapists, and mentors who deliver wrap-around support to provide families progress and lasting recovery. Kristina Saffran and Erin Parks co-founded the company in San Diego, California in 2019.

Equip Health

Series A in 2021
Equip is a virtual program helping families recover from eating disorders at home with comprehensive, gold-standard care created by experts in the field and people in recovery. Equip’s five-person care teams include dieticians, physicians, therapists, and mentors who deliver wrap-around support to provide families progress and lasting recovery. Kristina Saffran and Erin Parks co-founded the company in San Diego, California in 2019.

PatientsLikeMe

Venture Round in 2021
PatientsLikeMe, Inc. operates a healthcare data-sharing platform that facilitates the exchange of symptoms, treatments, health data, and personal experiences among patients, caregivers, healthcare professionals, and researchers. Founded in 2004 and based in Cambridge, Massachusetts, the platform serves over 600,000 members and focuses on a broad range of health conditions, including cancer, mental health, and chronic diseases. PatientsLikeMe enables users to discover new treatment options, connect with peers, and engage in health management to enhance their outcomes. The company collaborates with major pharmaceutical firms and government organizations to incorporate patient insights into research, development, and public policy. Additionally, PatientsLikeMe has published over 100 research studies, establishing itself as a credible resource for real-world disease information. It is a subsidiary of United Healthcare Services, Inc.

Alma

Series B in 2021
Alma is a membership-based network for mental health care providers that aims to improve access to high-quality, affordable mental health care. Its platform enables providers to accept insurance and also provides a member directory, client-matching service, scheduling, and billing functions, as well as education, training, and a community for support.

Sitka

Series A in 2021
Sitka, Inc. operates an online communication platform that connects patients with healthcare providers across various specialties, including endocrinology, neurology, orthopedics, pulmonology, and rheumatology. Founded in 2018 by experts in healthcare, technology, and policy, the company aims to transform specialty care in the United States by enhancing the capabilities of primary care providers and facilitating patient involvement in their care. The platform allows for personalized consultations, such as interpreting MRI results with board-certified doctors, thereby improving patients' understanding of their health conditions and enabling better decision-making. Headquartered in Carmel, California, Sitka is supported by a range of investors and is dedicated to fostering effective and trusted care delivery for all patients through its innovative solutions.

Greater Good Health

Seed Round in 2021
Greater Good Health is a healthcare organization focused on increasing access to value-based, holistic primary care, particularly in underserved and rural communities. Utilizing a Nurse Practitioner-led model, the organization collaborates with health plans to establish primary care practices and partners with risk-bearing organizations to implement private-labeled clinical programs. These initiatives aim to facilitate a transition to outcomes-focused care while enhancing patient experience. Greater Good Health's platform provides nurse practitioners with essential resources and tools to deliver quality, whole-person care, ultimately benefiting patients, providers, and payers alike by improving health outcomes and reducing overall costs.

Diameter Health

Series B in 2020
Diameter Health transforms patient information into the quantity and quality of interoperable data for healthcare organizations. The core of the Diameter Health platform is Fusion, which enables intelligent data exchange ingestion and cleansing through sophisticated normalization and cleansing processes. Data originating from any certified Electronic Health Record (EHR) is transformed into clinical information optimized for use at the point of care or to be consumed as a rich substrate for analytics.

Buoy Health

Series C in 2020
Buoy provides a personalized all-in-one platform to help guide consumers back to health. Whether it's chatting about symptoms with Buoy Assistant to get help in the moment of sickness or researching benefits through Buoy Dashboard, Buoy is available 24/7 to help make self-diagnosis and navigating the healthcare system simple and easy. For employers, Buoy can be custom configured to surface benefits information and wellness programs, guide employees to in-network providers, and fully integrate with other health portals. The company was founded in 2014 and is headquartered in Boston, Massachusetts.

Truepill

Series C in 2020
Truepill is a B2B pharmacy fulfillment service. They provide a pharmacy API and fulfillment of medications to 50 states from their own facilities. They work directly with D2C consumer brands (e.g. Hims, Nurx), digital health companies, and other healthcare organizations. They are a team of 150 employees and have raised funding from Initialized Capital, Y Combinator, Slow Ventures, Sound Ventures, Tuesday Capital, Foundation Capital, Index Ventures, Social Capital, Box Group, Joe Montana, and others. Founded in 2016 by Umar Afridi and Sid Viswanathan, Truepill is headquartered in San Mateo, California.

Lumeon

Series D in 2020
Lumeon Ltd. is a digital health company based in London, United Kingdom, specializing in care pathway management solutions for the healthcare sector. Founded in 2005 and formerly known as Qinec Ltd., Lumeon offers a cloud-based platform called Care Pathway Manager, which provides a comprehensive, real-time overview of the patient journey from referral to outcome. The company's services encompass business analysis, project management, configuration, data migration, training, and ongoing support. By focusing on the entire care pathway, Lumeon enables healthcare providers to unify clinical and administrative workflows, automate tasks, and achieve measurable healthcare outcomes. Its client base includes some of Europe's leading healthcare providers, such as BUPA, Nuffield Health, and HCA, reflecting the company's role in driving healthcare transformation.

mPulse Mobile

Series C in 2020
mPulse Mobile, Inc. develops healthcare communication technology solutions focused on consumer health and wellness. The company offers a cloud-based intelligent mobile messaging platform designed to address various challenges in healthcare, including missed appointments, medication adherence, and disease management. Its solutions encompass medication adherence, preventive care, chronic condition management, and optimizing call center operations, serving a diverse clientele that includes Medicare, Medicaid, commercial plans, health systems, and pharmacies. By integrating conversational AI and digital engagement strategies, mPulse Mobile helps healthcare organizations encourage customers to adopt healthier behaviors. Founded in 2014, the company is headquartered in Encino, California.

Truepill

Series B in 2020
Truepill is a B2B pharmacy fulfillment service. They provide a pharmacy API and fulfillment of medications to 50 states from their own facilities. They work directly with D2C consumer brands (e.g. Hims, Nurx), digital health companies, and other healthcare organizations. They are a team of 150 employees and have raised funding from Initialized Capital, Y Combinator, Slow Ventures, Sound Ventures, Tuesday Capital, Foundation Capital, Index Ventures, Social Capital, Box Group, Joe Montana, and others. Founded in 2016 by Umar Afridi and Sid Viswanathan, Truepill is headquartered in San Mateo, California.

DispatchHealth

Series C in 2020
DispatchHealth Management, LLC specializes in on-demand mobile and virtual healthcare services, aimed at delivering quality care directly to patients in their homes. Founded in 2013 and based in Denver, Colorado, the company provides a wide range of medical services, including evaluations for acute injuries and illnesses, laceration repairs, splinting, and treatment for conditions such as nosebleeds. Additionally, DispatchHealth offers vital medical procedures like Foley catheter and G-tube placements, medication administration, laboratory testing, and outpatient imaging arrangements. With a focus on convenience and integration, the company enhances the capabilities of patients' care teams while striving to reduce healthcare costs.

Somatus

Series C in 2020
Somatus, Inc. is a healthcare company based in McLean, Virginia, specializing in kidney care services. Founded in 2016, it partners with health plans, health systems, nephrology, and primary care groups to offer integrated care for patients with or at risk of developing kidney disease. The company provides a range of services, including home hemodialysis, peritoneal dialysis, in-center hemodialysis, kidney transplantation, and conservative care. Somatus focuses on delaying or preventing the progression of chronic kidney disease and aims to enhance the quality of care through improved coordination and increased utilization of home dialysis and transplantation options. Its approach combines vertically integrated clinical services and technology to optimize patient outcomes.

Kaia Health

Series B in 2020
Kaia Health is a digital therapeutics company that specializes in developing evidence-based treatments for various disorders, including back pain and chronic obstructive pulmonary disease (COPD). Founded in 2016 and headquartered in Brooklyn, New York, the company utilizes machine learning to provide personalized app interventions designed to empower patients in self-managing their conditions from home using familiar devices like smartphones and tablets. Kaia Health's platform delivers tailored daily plans that incorporate exercises, relaxation techniques, and educational content, allowing users to customize their programs according to personal preferences. To date, the company has enrolled over 400,000 users in its digital therapy program.

DocASAP

Venture Round in 2020
DocASAP Inc. develops a patient access and engagement software designed for health systems, health plans, and physician groups. The platform assists organizations in directing patients to the most suitable providers and care settings throughout their access journey. By providing care-driven engagement tools, reminders, and insights into patient access and operational performance, DocASAP enables healthcare organizations to manage provider information effectively. The intelligent matching capabilities of the platform facilitate connections between patients and providers, enhancing access and improving health outcomes while reducing costs. Founded in 2009 and headquartered in Herndon, Virginia, with an additional office in Noida, India, DocASAP aims to simplify patient access complexities and improve overall healthcare experiences.

Mindstrong

Series C in 2020
Mindstrong operates a virtual mental health platform designed to enhance mental well-being through the integration of care, data, and technology. The platform addresses personal, societal, and economic challenges related to mental health, utilizing a biomarker panel that assesses brain function based on passive and continuous interaction patterns from human-computer interfaces. This innovative approach allows expert clinicians to deliver evidence-based interventions while offering personalized support and therapy, making mental health care more accessible. Mindstrong has successfully assisted thousands of individuals, including those with serious mental illnesses, in improving their mental health and overall quality of life.

Holmusk

Series A in 2020
Holmusk is a health data analytics company focused on enhancing treatment for mental health and chronic diseases. It develops a real-world evidence platform that integrates specialty behavioral health data with advanced analytics to provide evidence-based insights for treatment decisions. By leveraging artificial intelligence and data science, Holmusk accelerates research and improves patient outcomes through predictive algorithms. Its proprietary modeling platform enables clients to analyze real-world data, facilitating personalized medicine and driving data-driven approaches in healthcare. The company's mission is to expand evidence-based care for individuals managing behavioral health conditions, ultimately supporting the commercialization of new treatments.

LetsGetChecked

Series C in 2020
LetsGetChecked is an at-home health testing platform that connects customers with regulated laboratory testing, enabling individuals to manage their health effectively. Based in New York, the company offers a wide range of testing kits for general wellness, sexual health, women's health, men's health, and specific illnesses, including cancer and fertility issues. Users can order testing kits online, collect samples such as blood or urine, and return them using prepaid envelopes. The analyzed results are then uploaded online, providing customers with convenient access to their health information. LetsGetChecked operates nationwide in the United States and extends its services to Canada and Europe, promoting a patient-led approach to healthcare through technology.

Heartbeat Health

Series A in 2020
Heartbeat Health, Inc. is a healthcare technology company based in New York that specializes in providing virtual cardiovascular disease prevention and management services. Founded in 2017, it offers a data-driven platform that enables real-time consultations between patients and cardiologists. Through its web-based services, Heartbeat Health facilitates secure communication, allowing patients to receive medical advice, treatment, and dietary consultations from healthcare professionals. The company's focus is on reducing cardiovascular risk and improving patient outcomes by promoting continuous engagement and monitoring of heart health. By leveraging technology, Heartbeat Health aims to enhance the quality of care for patients and support at-risk organizations in managing cardiovascular conditions more effectively.

RubiconMD

Series C in 2020
RubiconMD, Inc. operates an online platform that facilitates communication between primary care clinicians and specialists through its eConsult service. This platform allows primary care providers to seek expert guidance on medical cases, thereby enhancing patient care and reducing healthcare costs. In addition to the eConsult service, RubiconMD offers a continuing medical education (CME) program for eConsult submissions, live and on-demand webinars, and RubiconRx, a clinical pharmacy platform that supports patient medication access. The company also provides support in electronic health records, workflow integration, onboarding, and clinician engagement. Founded in 2013 and headquartered in New York, RubiconMD serves a diverse clientele, including employers, community health centers, correctional health facilities, health plans, and direct primary care practices.

Scipher Medicine

Series B in 2020
Scipher Medicine is a biotechnology company that has developed a precision medicine platform aimed at improving drug therapy outcomes for patients with cardiovascular and autoimmune diseases. The company's flagship products, including PrismDx, PrismRA, and PrismUC, utilize molecular testing to predict patient responses to specific drug therapies, enabling healthcare providers to prescribe more effective treatments tailored to individual patient needs. For example, PrismRA identifies rheumatoid arthritis patients who are unlikely to respond to certain anti-TNF therapies, allowing for timely alternative treatments. By leveraging a simple blood sample to analyze RNA and generate genomic signatures, Scipher Medicine helps healthcare professionals select the most suitable therapies based on the underlying biology of diseases rather than relying on traditional classifications or symptomatic assessments. This innovative approach not only enhances patient care but also addresses significant inefficiencies in the healthcare system, reducing costs associated with ineffective treatments. Scipher Medicine, incorporated in 2013 and based in Waltham, Massachusetts, aims to transform drug prescribing and development through its advanced molecular technology.

Oxford VR

Series A in 2020
Oxford VR Limited specializes in developing cognitive treatments for various clinical conditions using virtual reality technology. Founded in 2016 and based in Oxford, United Kingdom, the company leverages extensive research from Professor Daniel Freeman to create automated therapies delivered by a virtual coach. These innovative treatments address issues such as fear of heights, psychosis, and social anxiety. By utilizing immersive VR experiences, Oxford VR aims to provide faster, more effective, and cost-efficient psychological interventions compared to traditional methods. The company's focus is on delivering clinically validated and user-centered solutions that enhance access to mental health care, benefiting patients, healthcare professionals, and the broader health system.

CareBridge Health

Series B in 2019
CareBridge is a technology and services provider based in Nashville, Tennessee, dedicated to improving the lives of individuals with physical, intellectual, or developmental disabilities who receive home and community-based services. Founded in 2009, the company specializes in assisting health plans and states by offering comprehensive solutions such as electronic visit verification, data aggregation, and 24/7 clinical support. CareBridge focuses on ensuring that Medicaid recipients, as well as those dually eligible for Medicare and Medicaid, receive the necessary services, equipment, and support to maintain their independence at home. By facilitating continuous communication between patients, their families, and caregivers, CareBridge enhances the quality of care and promotes a supportive environment for those they serve.

Contessa

Series D in 2019
Contessa, based in Nashville, specializes in Home Recovery Care, a model designed to deliver inpatient hospital care directly in patients' homes. Founded in 2015, the company offers a comprehensive range of services, including acute care, post-acute care, and surgical procedures, supported by its proprietary health informatics platform. This innovative approach allows health systems to enhance their care delivery by treating patients outside of traditional hospital settings, ultimately leading to improved patient outcomes and experiences. Contessa's solutions provide significant cost savings for health plans, enabling a more efficient and effective healthcare model.

Apervita

Venture Round in 2019
With wasteful healthcare spending in the U.S. estimated at $935 billion, we take our role as a healthcare innovator very seriously. Simply put, we’re on a mission to transform quality measurement and care delivery. To drive toward a Learning Health System—a framework that drives better outcomes and cost efficiencies across the health ecosystem—the industry has to commit to real change. Apervita is that change. Through our solutions and trusted collaboration platform, we’re committed to making the Learning Health System a reality, making healthcare smarter and ultimately improving patient care. As we move into our next phase of growth, we’re looking for passionate and fearless professionals to help us pursue our mission. We’ve earned the trust of our investors, including Optum Ventures, Baird Capital, Pritzker Group Venture Capital and Math Venture Partners, to further grow and scale our business. We’ve also been recognized as an industry leader by Gartner, CIOReview, Healthcare Tech Outlook, and Healthcare Informatics. Always in search of the next “first,” Apervita was named the first company to certify electronic clinical quality measures from the National Committee for Quality Assurance (NCQA) using our proprietary clinical quality language (CQL) ingestion engine. And, we were recently awarded by Healthcare Innovation for our innovative work with The Joint Commission, one of the nation’s largest regulatory organizations. We believe we’re making a difference every day to drive improvements in quality care that lead to better patient outcomes with a lower cost of care. We’re honored to be on this incredibly important journey to build a better healthcare system.

Kaia Health

Series A in 2019
Kaia Health is a digital therapeutics company that specializes in developing evidence-based treatments for various disorders, including back pain and chronic obstructive pulmonary disease (COPD). Founded in 2016 and headquartered in Brooklyn, New York, the company utilizes machine learning to provide personalized app interventions designed to empower patients in self-managing their conditions from home using familiar devices like smartphones and tablets. Kaia Health's platform delivers tailored daily plans that incorporate exercises, relaxation techniques, and educational content, allowing users to customize their programs according to personal preferences. To date, the company has enrolled over 400,000 users in its digital therapy program.

Vim

Series B in 2019
Vim, Inc. is a healthcare technology company founded in 2015 and based in San Francisco, California. The company develops a platform that enhances the connection between patients and healthcare providers by offering online services for finding, scheduling, and receiving care. Its solutions include online booking and referral coordination, facilitating seamless communication and data sharing among health plans, patients, and a wide range of medical providers, from independent practitioners to large healthcare systems. Vim's platform integrates with electronic health records, enabling real-time access to patient data and insights at the point of care. By improving connectivity within clinical operations, Vim aims to support the delivery of affordable, high-quality healthcare.

Buoy Health

Series B in 2019
Buoy provides a personalized all-in-one platform to help guide consumers back to health. Whether it's chatting about symptoms with Buoy Assistant to get help in the moment of sickness or researching benefits through Buoy Dashboard, Buoy is available 24/7 to help make self-diagnosis and navigating the healthcare system simple and easy. For employers, Buoy can be custom configured to surface benefits information and wellness programs, guide employees to in-network providers, and fully integrate with other health portals. The company was founded in 2014 and is headquartered in Boston, Massachusetts.

icometrix

Series A in 2019
icometrix is a company that specializes in the analysis of brain MRI scans to enhance personalized care for patients with neurological disorders. Founded in 2011 as a spin-off from the universities and university hospitals of Leuven and Antwerp, icometrix is headquartered in Leuven, Belgium, with an additional office in Boston, USA. The company has developed MSmetrix, a tool that identifies brain lesions, measures lesion volume, and assesses whole brain and grey matter volume and atrophy. MSmetrix has received market approval in the EU and several other countries, with FDA clearance pending. icometrix is recognized as a leader in MRI biomarkers for routine clinical practice and is certified in quality management and information security. Additionally, the company provides image analysis services for clinical trials and research studies, utilizing its software-as-a-service model to process large volumes of brain imaging data. This approach aids in advancing research on various neurological conditions, including traumatic brain injury, epilepsy, Alzheimer’s disease, and stroke, by using imaging biomarker outcomes as key endpoints in drug development.

Diameter Health

Series A in 2019
Diameter Health transforms patient information into the quantity and quality of interoperable data for healthcare organizations. The core of the Diameter Health platform is Fusion, which enables intelligent data exchange ingestion and cleansing through sophisticated normalization and cleansing processes. Data originating from any certified Electronic Health Record (EHR) is transformed into clinical information optimized for use at the point of care or to be consumed as a rich substrate for analytics.

AbleTo

Corporate Round in 2019
AbleTo is a leading provider of virtual behavioral health care. Deep behavioral health insights and an integrated proprietary platform identifies and engages the right patients with the right support – when and how they want it. Their proven programs improve clinical outcomes and lower health care costs. AbleTo is committed to reach people with unmet behavioral health needs and eliminate barriers through virtual care. Their high-quality behavioral health care delivers results for their patients and their clients. AbleTo is proven to improve health outcomes and reduce medical costs with a program that earns high satisfaction scores from patients.

Recover Together

Venture Round in 2019
Recover Together, Inc. operates private clinics that specialize in treating opioid addiction through a comprehensive approach that includes medication-assisted treatment and therapy. Founded in 2014 and headquartered in Manchester, New Hampshire, the company offers services across multiple states, including California, Indiana, Maine, Michigan, West Virginia, and North Carolina. Its treatment model combines the use of Suboxone (buprenorphine) with weekly group therapy sessions, allowing patients to engage in a supportive community while working toward their recovery goals. The organization is committed to making addiction treatment respectful, accessible, and affordable, empowering individuals to regain control of their lives and improve their overall quality of life.

Digital Diagnostics

Series A in 2018
Digital Diagnostics Inc. is an artificial intelligence diagnostics company focused on enhancing the quality, accessibility, and affordability of healthcare through advanced technology. Founded in 2010 in Coralville, Iowa, by Michael Abramoff, the company has developed a range of autonomous algorithms that analyze medical images to detect various diseases. Its flagship products include IDx-DR for diabetic retinopathy, IDx-G for glaucoma indicators, and IDx-AMD for age-related macular degeneration. Additionally, Digital Diagnostics provides algorithms for detecting other conditions such as Alzheimer's disease and cardiovascular risks. By eliminating the diagnostic burden from specialists, the company's AI platform aims to establish a new standard of care, democratizing healthcare and improving patient outcomes. The company collaborates with patient advocacy groups and regulatory bodies to facilitate the adoption of its innovative solutions both in the United States and internationally.

Mindstrong

Series B in 2018
Mindstrong operates a virtual mental health platform designed to enhance mental well-being through the integration of care, data, and technology. The platform addresses personal, societal, and economic challenges related to mental health, utilizing a biomarker panel that assesses brain function based on passive and continuous interaction patterns from human-computer interfaces. This innovative approach allows expert clinicians to deliver evidence-based interventions while offering personalized support and therapy, making mental health care more accessible. Mindstrong has successfully assisted thousands of individuals, including those with serious mental illnesses, in improving their mental health and overall quality of life.

RubiconMD

Series B in 2018
RubiconMD, Inc. operates an online platform that facilitates communication between primary care clinicians and specialists through its eConsult service. This platform allows primary care providers to seek expert guidance on medical cases, thereby enhancing patient care and reducing healthcare costs. In addition to the eConsult service, RubiconMD offers a continuing medical education (CME) program for eConsult submissions, live and on-demand webinars, and RubiconRx, a clinical pharmacy platform that supports patient medication access. The company also provides support in electronic health records, workflow integration, onboarding, and clinician engagement. Founded in 2013 and headquartered in New York, RubiconMD serves a diverse clientele, including employers, community health centers, correctional health facilities, health plans, and direct primary care practices.

Apervita

Venture Round in 2017
With wasteful healthcare spending in the U.S. estimated at $935 billion, we take our role as a healthcare innovator very seriously. Simply put, we’re on a mission to transform quality measurement and care delivery. To drive toward a Learning Health System—a framework that drives better outcomes and cost efficiencies across the health ecosystem—the industry has to commit to real change. Apervita is that change. Through our solutions and trusted collaboration platform, we’re committed to making the Learning Health System a reality, making healthcare smarter and ultimately improving patient care. As we move into our next phase of growth, we’re looking for passionate and fearless professionals to help us pursue our mission. We’ve earned the trust of our investors, including Optum Ventures, Baird Capital, Pritzker Group Venture Capital and Math Venture Partners, to further grow and scale our business. We’ve also been recognized as an industry leader by Gartner, CIOReview, Healthcare Tech Outlook, and Healthcare Informatics. Always in search of the next “first,” Apervita was named the first company to certify electronic clinical quality measures from the National Committee for Quality Assurance (NCQA) using our proprietary clinical quality language (CQL) ingestion engine. And, we were recently awarded by Healthcare Innovation for our innovative work with The Joint Commission, one of the nation’s largest regulatory organizations. We believe we’re making a difference every day to drive improvements in quality care that lead to better patient outcomes with a lower cost of care. We’re honored to be on this incredibly important journey to build a better healthcare system.

Buoy Health

Series A in 2017
Buoy provides a personalized all-in-one platform to help guide consumers back to health. Whether it's chatting about symptoms with Buoy Assistant to get help in the moment of sickness or researching benefits through Buoy Dashboard, Buoy is available 24/7 to help make self-diagnosis and navigating the healthcare system simple and easy. For employers, Buoy can be custom configured to surface benefits information and wellness programs, guide employees to in-network providers, and fully integrate with other health portals. The company was founded in 2014 and is headquartered in Boston, Massachusetts.

Mindstrong

Series A in 2017
Mindstrong operates a virtual mental health platform designed to enhance mental well-being through the integration of care, data, and technology. The platform addresses personal, societal, and economic challenges related to mental health, utilizing a biomarker panel that assesses brain function based on passive and continuous interaction patterns from human-computer interfaces. This innovative approach allows expert clinicians to deliver evidence-based interventions while offering personalized support and therapy, making mental health care more accessible. Mindstrong has successfully assisted thousands of individuals, including those with serious mental illnesses, in improving their mental health and overall quality of life.

SHYFT

Series B in 2017
SHYFT Analytics, Inc. specializes in providing cloud-based data management and analytics solutions tailored for the life sciences industry, both in the United States and internationally. The company’s platform integrates clinical and commercial data, enabling life sciences organizations to derive patient-centric intelligence and analytics. This functionality supports various operational needs, including sales strategies, market access, and product launches, effectively shortening development cycles and enhancing the likelihood of successful commercialization. SHYFT offers specialized solutions such as sales insights, market intelligence for product launches, and integrated data for rare diseases. The organization also provides services in launch and commercial analytics, clinical operations, and insight-driven design. Founded in 2002 and based in Waltham, Massachusetts, SHYFT operates as a subsidiary of Medidata Solutions and has a strategic partnership with PAREXEL International.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.